Supplement May Cut Men’s Cancer, Heart Ailments (NAPSA)—A recent study found that men who took a combination of selenium, lycopene, cligopyrocyanidin, vitamin E, and zinc developed fewer prostate cancers than predicted and no other types of cancer. This study surveyed men who have taken a supplement containing thefive listed ingredients plus beta sitosterol beginning in 1999. | 7 All men in the survey were at high risk of cancer and cardiovascular events due to aging. Their ages are from 51 to 90-plus. Instead of 14 or more new cases of prostate cancer predicted, only six were reported. Of these, three men were treated and consider themselves cured. The other 3 men chose conservative management to avoid surgery andradiation. No other cancers of any type have been found. Cardiovascular research has found that men with high blood pressure are 81 percent more likely to die prematurely than menfree from such pressure. Nearly 45 percent of the surveyed men reported taking up to four drugs to control cardiovascular threats, disclosing their high risks of heart/brain attacks (strokes). Instead of finding 13 to 18 heart/brain attacks in these high- i Ross Z. Pierpont, M.D., F.A.C.S., Chief of Surgery at a teaching hospital more than 15 years. risk men, actual cases were one heart attack and onestroke. Both menreported full recovery. Other parts of the Malegard 2005 Survey include the use of PSA “velocity”— * as an improved, more accurate test for prostate cancer, espe- cially men with low PSAlevels, * to managefailed therapies. The report also covers prostatitis and the actual experience of 41 menin their own words. For a free copy of the Report, call 1-800-685-4912 or write to Ross Z. Pierpont, M.D., Box 450, Camp Meade Rd., Linthicum, MD 21090.
